Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,993 public trials 1,264 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Completed

A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

NCT04468607

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • City of Hope Duarte, California, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
  • Clinica Universitaria de Navarra Pamplona, Navarre, Spain
View Trial Details
Completed

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

NCT03428958

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +13 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)

NCT04907539

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Community Health Network Cancer Center North - Community Hospital Network Indianapolis, Indiana, United States
  • OptumCare Cancer Care Las Vegas, Nevada, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
View all 22 locations
View Trial Details
Completed

A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

NCT04322539

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC-HOPE Tucson, Arizona, United States
  • California Research Institute (CRI) Los Angeles, California, United States
  • City of Hope Comprehensive Cancer Center Los Angeles, California, United States
View all 153 locations
View Trial Details
Completed

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

NCT04330664

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations
  • Local Institution - 002-805 Los Angeles, California, United States
  • Local Institution - 002-803 Orange, California, United States
  • Local Institution - 002-828 Chicago, Illinois, United States
  • Local Institution - 002-942 Wichita, Kansas, United States
View all 17 locations
View Trial Details

Related conditions